Skip to main content
. Author manuscript; available in PMC: 2022 Aug 18.
Published in final edited form as: Cancer Res Commun. 2022 Feb 11;2(2):90–98. doi: 10.1158/2767-9764.CRC-21-0142

Figure 2. Receiver operating curve (ROC) of mSEPT9 comparison between EOCRC cases and healthy controls.

Figure 2.

The ROC was generated by comparing the mSEPT9 cycle threshold (Ct) values of EOCRC cases and all healthy controls. The AUC (0.89) was statistically significant (standard error=0.04, 95% CI=0.81–0.97, p<0.001).